Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Treatment Effect on Paraoxonase in Hypogonadotrophic Hypogonadism
NCT01107067Phase 4Completed
- Sponsor
- Gulhane School of Medicine
- Start
- Jun 2008
- Primary completion
- Dec 2009
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of Sustanon 250 in hypogonadotropic hypogonadism (HH), sponsored by Gulhane School of Medicine. Started Jun 2008; status: completed.
02
Drugs
Sustanon 250
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT01107067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01107067.